South and Central America Point-of-Care Molecular Diagnostics Market

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028

Analysis By Product & Services (Assays and Kits, Instruments, and Services and Software), Technology (PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others)

No. of Pages: 167
Report Code: TIPRE00026194
Category: Life Sciences
South and Central America Point-of-Care Molecular Diagnostics Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. South and Central America Point-of-Care Molecular Diagnostics Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. South and Central America Point-of-Care Molecular Diagnostics Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. South and Central America Point-of-Care Molecular Diagnostics Market Regional Analysis

6.2 South and Central America Point-of-Care Molecular Diagnostics Market Revenue 2019-2028 (US$ Million)
6.3 South and Central America Point-of-Care Molecular Diagnostics Market Forecast Analysis

7. South and Central America Point-of-Care Molecular Diagnostics Market Analysis – by Product & Services

7.1 Assays and Kits
  • 7.1.1 Overview
  • 7.1.2 Assays and Kits: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Instruments
  • 7.2.1 Overview
  • 7.2.2 Instruments: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Services and Software
  • 7.3.1 Overview
  • 7.3.2 Services and Software: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. South and Central America Point-of-Care Molecular Diagnostics Market Analysis – by Technology

8.1 PCR
  • 8.1.1 Overview
  • 8.1.2 PCR: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Isothermal Nucleic Acid Amplification Technology
  • 8.2.1 Overview
  • 8.2.2 Isothermal Nucleic Acid Amplification Technology: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Other Technologies
  • 8.3.1 Overview
  • 8.3.2 Other Technologies: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. South and Central America Point-of-Care Molecular Diagnostics Market Analysis – by Application

9.1 Infectious Diseases
  • 9.1.1 Overview
  • 9.1.2 Infectious Diseases: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Oncology
  • 9.2.1 Overview
  • 9.2.2 Oncology: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Hematology
  • 9.3.1 Overview
  • 9.3.2 Hematology: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.4 Prenatal Testing
  • 9.4.1 Overview
  • 9.4.2 Prenatal Testing: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.5 Endocrinology
  • 9.5.1 Overview
  • 9.5.2 Endocrinology: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.6 Other Applications
  • 9.6.1 Overview
  • 9.6.2 Other Applications: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. South and Central America Point-of-Care Molecular Diagnostics Market Analysis – by End User

10.1 Hospitals and Clinics
  • 10.1.1 Overview
  • 10.1.2 Hospitals and Clinics: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Diagnostic Laboratories
  • 10.2.1 Overview
  • 10.2.2 Diagnostic Laboratories: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.3 Research and Academic Institutes
  • 10.3.1 Overview
  • 10.3.2 Research and Academic Institutes: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast, 2019-2028 (US$ Million)

11. South and Central America Point-of-Care Molecular Diagnostics Market – South and Central America Analysis

11.1 Overview

11.2 South and Central America
  • 11.2.1 South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 11.2.1.1 South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 Brazil: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.1.1 Brazil: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.1.2 Brazil: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.1.3 Brazil: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
    • 11.2.1.1.4 Brazil: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by End User
  • 11.2.1.2 Argentina: South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.2.1 Argentina: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.2.2 Argentina: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.2.3 Argentina: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
    • 11.2.1.2.4 Argentina: South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by End User
  • 11.2.1.3 Rest of South and Central America : South and Central America Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
    • 11.2.1.3.1 Rest of South and Central America : South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Product & Services
    • 11.2.1.3.2 Rest of South and Central America : South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Technology
    • 11.2.1.3.3 Rest of South and Central America : South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by Application
    • 11.2.1.3.4 Rest of South and Central America : South and Central America Point-of-Care Molecular Diagnostics Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 bioMérieux SA
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd.
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Danaher Corporation
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Enzo Biochem, Inc.
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 Abbott
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Meridian BioScience, Inc.
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Biocartis
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 Quidel Corporation
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Bio-Rad Laboratories, Inc.
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - South and Central America Point-of-Care Molecular Diagnostics Market

  • bioMérieux SA
  • F. Hoffmann-La Roche Ltd.
  • Danaher Corporation
  • Enzo Biochem, Inc.
  • Abbott
  • Meridian BioScience, Inc.
  • Biocartis
  • Quidel Corporation
  • Bio-Rad Laboratories, Inc.
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)